HBL and LND human melanoma cells were kindly provided by Professor G. Ghanem (Institut Bordet, Belgium).
Dr..
Philippe Ghanem (born 4 October 1980), a Swiss national, is a ‘C’ suite executive who is seen as an innovator and visionary in global financial markets. As an investor and an expert in trading a range of asset classes, he has developed a reputation for building financial services companies based on his insight and understanding of trading systems.
He and how these are driven by changes in market conditions, regulation and technology.